vs
Side-by-side financial comparison of GRAHAM CORP (GHM) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $56.7M, roughly 1.3× GRAHAM CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 20.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $2.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.5%).
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GHM vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.7M | $75.5M |
| Net Profit | $2.8M | — |
| Gross Margin | 23.8% | 69.3% |
| Operating Margin | 5.5% | 22.7% |
| Net Margin | 5.0% | — |
| Revenue YoY | 20.5% | 27.7% |
| Net Profit YoY | 79.2% | — |
| EPS (diluted) | $0.25 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.7M | $75.5M | ||
| Q3 25 | $66.0M | $54.5M | ||
| Q2 25 | $55.5M | $52.4M | ||
| Q1 25 | $59.3M | $46.0M | ||
| Q4 24 | $47.0M | $59.1M | ||
| Q3 24 | $53.6M | $80.5M | ||
| Q2 24 | $50.0M | $47.1M | ||
| Q1 24 | $49.1M | $43.8M |
| Q4 25 | $2.8M | — | ||
| Q3 25 | $3.1M | $8.8M | ||
| Q2 25 | $4.6M | $5.9M | ||
| Q1 25 | $4.4M | $3.0M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $3.3M | $20.3M | ||
| Q2 24 | $3.0M | $-4.5M | ||
| Q1 24 | $1.3M | $-4.8M |
| Q4 25 | 23.8% | 69.3% | ||
| Q3 25 | 21.7% | 77.7% | ||
| Q2 25 | 26.5% | 76.5% | ||
| Q1 25 | 27.0% | 77.1% | ||
| Q4 24 | 24.8% | 76.4% | ||
| Q3 24 | 23.9% | 63.9% | ||
| Q2 24 | 24.8% | 77.4% | ||
| Q1 24 | 25.9% | 75.5% |
| Q4 25 | 5.5% | 22.7% | ||
| Q3 25 | 6.5% | 17.6% | ||
| Q2 25 | 8.9% | 12.7% | ||
| Q1 25 | 9.3% | 8.7% | ||
| Q4 24 | 4.7% | 22.6% | ||
| Q3 24 | 7.9% | 27.4% | ||
| Q2 24 | 6.5% | -4.6% | ||
| Q1 24 | 3.1% | -5.3% |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 4.7% | 16.2% | ||
| Q2 25 | 8.3% | 11.2% | ||
| Q1 25 | 7.4% | 6.5% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 6.1% | 25.2% | ||
| Q2 24 | 5.9% | -9.6% | ||
| Q1 24 | 2.7% | -11.0% |
| Q4 25 | $0.25 | $0.26 | ||
| Q3 25 | $0.28 | $0.17 | ||
| Q2 25 | $0.42 | $0.12 | ||
| Q1 25 | $0.40 | $0.06 | ||
| Q4 24 | $0.14 | $0.40 | ||
| Q3 24 | $0.30 | $0.41 | ||
| Q2 24 | $0.27 | $-0.09 | ||
| Q1 24 | $0.11 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.3M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $131.3M | $130.3M |
| Total Assets | $292.9M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.3M | $97.5M | ||
| Q3 25 | $20.6M | $94.4M | ||
| Q2 25 | $10.8M | $96.0M | ||
| Q1 25 | $21.6M | $93.2M | ||
| Q4 24 | $30.0M | $101.0M | ||
| Q3 24 | $32.3M | $96.7M | ||
| Q2 24 | $21.6M | $96.8M | ||
| Q1 24 | $16.9M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $131.3M | $130.3M | ||
| Q3 25 | $127.6M | $115.3M | ||
| Q2 25 | $123.4M | $104.7M | ||
| Q1 25 | $119.6M | $97.1M | ||
| Q4 24 | $114.4M | $92.1M | ||
| Q3 24 | $112.5M | $71.1M | ||
| Q2 24 | $108.2M | $48.5M | ||
| Q1 24 | $105.6M | $51.0M |
| Q4 25 | $292.9M | $216.3M | ||
| Q3 25 | $287.0M | $202.9M | ||
| Q2 25 | $252.3M | $194.9M | ||
| Q1 25 | $264.1M | $196.2M | ||
| Q4 24 | $264.3M | $213.3M | ||
| Q3 24 | $249.5M | $220.7M | ||
| Q2 24 | $244.2M | $205.0M | ||
| Q1 24 | $233.9M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.8M | $14.4M |
| Free Cash FlowOCF − Capex | $2.4M | $14.4M |
| FCF MarginFCF / Revenue | 4.3% | 19.1% |
| Capex IntensityCapex / Revenue | 4.1% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.8M | $14.4M | ||
| Q3 25 | $13.6M | $9.7M | ||
| Q2 25 | $-2.3M | $14.1M | ||
| Q1 25 | $-3.6M | $3.6M | ||
| Q4 24 | $5.2M | $15.6M | ||
| Q3 24 | $13.9M | $11.0M | ||
| Q2 24 | $8.7M | $1.0M | ||
| Q1 24 | $8.6M | $11.2M |
| Q4 25 | $2.4M | $14.4M | ||
| Q3 25 | $9.4M | $9.7M | ||
| Q2 25 | $-9.3M | $14.1M | ||
| Q1 25 | $-8.7M | $3.6M | ||
| Q4 24 | $-2.1M | $15.6M | ||
| Q3 24 | $10.4M | $11.0M | ||
| Q2 24 | $5.7M | $1.0M | ||
| Q1 24 | $4.6M | — |
| Q4 25 | 4.3% | 19.1% | ||
| Q3 25 | 14.3% | 17.7% | ||
| Q2 25 | -16.7% | 26.8% | ||
| Q1 25 | -14.7% | 7.7% | ||
| Q4 24 | -4.5% | 26.4% | ||
| Q3 24 | 19.5% | 13.7% | ||
| Q2 24 | 11.5% | 2.1% | ||
| Q1 24 | 9.4% | — |
| Q4 25 | 4.1% | 0.0% | ||
| Q3 25 | 6.3% | 0.0% | ||
| Q2 25 | 12.6% | 0.0% | ||
| Q1 25 | 8.7% | 0.1% | ||
| Q4 24 | 15.6% | 0.0% | ||
| Q3 24 | 6.5% | 0.0% | ||
| Q2 24 | 6.0% | 0.0% | ||
| Q1 24 | 8.2% | 0.0% |
| Q4 25 | 1.67× | — | ||
| Q3 25 | 4.40× | 1.10× | ||
| Q2 25 | -0.49× | 2.41× | ||
| Q1 25 | -0.81× | 1.21× | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 4.25× | 0.54× | ||
| Q2 24 | 2.94× | — | ||
| Q1 24 | 6.45× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
PBYI
Segment breakdown not available.
